Where does the value of ‘value-added’ pharmaceuticals come from?

Author(s): Fereshteh Barei, PhD

Abstract: The role of sound science, discovery, and innovation in value-added pharmaceuticals has not been sufficiently considered. This term is mainly used to define improved version of generic drugs. The concept of value-added pharmaceuticals has been picked up by different groups of companies, some are aiming to increase willingness to pay for their modified pharmaceutical […]

Read more →